Profil
Wouter Meuleman is currently a Director & Investor at Fluent BioSciences, Inc. He is also a Board Member at RedShift Bioanalytics, Inc. and a Partner at IIF Management Co. LLC.
Additionally, he serves as a Board Observer at DNA Script SAS, Biota Technology, Inc., and Delfi Diagnostics, Inc. In his former positions, Dr. Meuleman worked as a Director at Illumina, Inc. from 2015 to 2019.
He also served as a Board Observer at Desktop Genetics Ltd. from 2015 to 2018.
Furthermore, he was a Senior Scientist at Oxamer from 2003 to 2004.
Dr. Meuleman obtained an MBA from the University of Cambridge.
He holds a doctorate degree from Newcastle University and an undergraduate degree from Ghent University.
Aktive Positionen von Wouter Meuleman
| Unternehmen | Position | Beginn |
|---|---|---|
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01.02.2016 |
Fluent BioSciences, Inc.
Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops differentiated single-cell technology products | Direktor/Vorstandsmitglied | - |
RedShiftBio Bioanalytics, Inc.
RedShiftBio Bioanalytics, Inc. Packaged SoftwareTechnology Services Develops reimagine and reengineer analytical tools in life science research & biopharmaceutical drug development | Direktor/Vorstandsmitglied | 01.10.2021 |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Direktor/Vorstandsmitglied | 01.08.2019 |
Biota Technology, Inc.
Biota Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops deoxyribonucleic acid sequencing and data sciences to explore the earth’s sub surfaces | Direktor/Vorstandsmitglied | 01.10.2015 |
DNA Script SAS
DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Direktor/Vorstandsmitglied | 01.08.2017 |
Ehemalige bekannte Positionen von Wouter Meuleman
| Unternehmen | Position | Ende |
|---|---|---|
| ILLUMINA, INC. | Direktor/Vorstandsmitglied | 01.03.2019 |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Direktor/Vorstandsmitglied | 01.07.2018 |
Oxamer | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2004 |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Wouter Meuleman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
RedShiftBio Bioanalytics, Inc.
RedShiftBio Bioanalytics, Inc. Packaged SoftwareTechnology Services Develops reimagine and reengineer analytical tools in life science research & biopharmaceutical drug development | Technology Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle University
Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Technology Services |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Finance |
DNA Script SAS
DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Commercial Services |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Health Technology |
Biota Technology, Inc.
Biota Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops deoxyribonucleic acid sequencing and data sciences to explore the earth’s sub surfaces | Commercial Services |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Health Services |
Fluent BioSciences, Inc.
Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops differentiated single-cell technology products | Commercial Services |
Oxamer |
















